59200-40-7

Usage

Uses

Used in Pharmaceutical Industry:
Lanosten-3-ol-32-al is used as a pharmaceutical compound for its potential therapeutic properties. The expression is: lanosten-3-ol-32-al is used as a therapeutic agent for its unique molecular structure that may contribute to the development of new drugs and treatments.
Used in Cosmetic Industry:
Lanosten-3-ol-32-al is used as an ingredient in the cosmetic industry for its potential benefits to skin health and appearance. The expression is: lanosten-3-ol-32-al is used as a cosmetic ingredient for its potential to improve skin hydration, elasticity, and overall health.
Used in Chemical Research:
Lanosten-3-ol-32-al is used as a subject of study in chemical research for its unique properties and potential applications in various fields. The expression is: lanosten-3-ol-32-al is used as a research subject for its potential to contribute to the advancement of chemical knowledge and the development of new technologies.

InChI:InChI=1/C30H50O2/c1-20(2)9-8-10-21(3)22-14-18-30(19-31)24-11-12-25-27(4,5)26(32)15-16-28(25,6)23(24)13-17-29(22,30)7/h19-22,25-26,32H,8-18H2,1-7H3/t21-,22-,25?,26+,28-,29-,30-/m1/s1

Upstream product

• 136203-64-0 Acetic acid (3S,5R,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-14-hydroxymethyl-4,4,10,13-tetramethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 
• 130257-83-9 2,2-Dimethyl-propionic acid (3S,5R,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-4,4,10,13-tetramethyl-15-oxo-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 
• 4489-03-6 3β-acetoxylanostan-7α,32-oxide 
• 59200-39-4 lanost-8-en-3β,32-diol 
• 4489-02-5 3β-acetoxylanostan-7α-ol 
• 59200-44-1 (5R,10S,13R,14S,17R)-17-((R)-1,5-Dimethyl-hexyl)-4,4,10,13-tetramethyl-3-oxo-1,2,3,4,5,6,7,10,11,12,13,15,16,17-tetradecahydro-cyclopenta[a]phenanthrene-14-carbaldehyde 
• 119318-39-7 Acetic acid (3S,5R,10S,13R,14S,17R)-17-((R)-1,5-dimethyl-hexyl)-14-formyl-4,4,10,13-tetramethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl ester 
• 136203-69-5 (3S,5R,10S,13R,14R,17R)-14-Benzyloxymethyl-17-((R)-1,5-dimethyl-hexyl)-3-hydroxy-4,4,10,13-tetramethyl-1,2,3,4,5,6,7,10,11,12,13,14,16,17-tetradecahydro-cyclopenta[a]phenanthren-15-one 

Relevant academic research and scientific papers

Efficient preparation of 32-oxygenated lanosterol derivatives

An efficient synthesis of 32-hydroxy- and 32-oxo-lanost-8-en-3β-ol (2 and 4) from the 8-ene-15-ketone 7 was described.